Astrocyte
Star-shaped (Greek: astron) glial cells that are indispensable partners to every neuron. They supply metabolic fuel via the astrocyte-neuron lactate shuttle, clear >90% of synaptic glutamate via GLT-1/GLAST transporters, buffer extracellular K⁺ via Kir4.1, maintain BBB integrity via AQP4 endfeet, and form the third element of the tripartite synapse. Reactive gliosis in injury drives both neuroprotective and scar-forming programs.
Overview
Astrocytes are the most abundant cell type in the central nervous system — star-shaped glial cells that are indispensable partners to every neuron. Far from passive structural scaffolding, astrocytes are active participants in neural computation: they form the third arm of the tripartite synapse, supply metabolic fuel via the astrocyte-neuron lactate shuttle, clear neurotransmitters, buffer extracellular ions, regulate cerebral blood flow, and maintain the blood-brain barrier.
Two major subtypes dominate the CNS: protoplasmic astrocytes (grey matter; highly branched, each cell contacting ~140,000 synapses) and fibrous astrocytes (white matter; fewer branches; envelop nodes of Ranvier). A third subtype, Bergmann glia, is restricted to the cerebellar cortex and guides Purkinje cell dendritogenesis. Together these cells tile the CNS in largely non-overlapping spatial domains, each astrocyte governing its own synaptic territory.
Astrocytes communicate with each other via gap junctions composed of Connexin-43 (Cx43) and Cx30, forming a functional syncytium that spatially redistributes K⁺ and metabolites over large distances. Ca²⁺ waves propagating through this network link astrocyte activity to neurovascular coupling — the cellular basis of the BOLD signal measured by fMRI.
Structure — Morphology and Subtypes
| Feature / Subtype | Detail |
|---|---|
| Soma size | 9–25 µm diameter; star-shaped with extensive fine processes radiating from soma |
| Canonical marker | GFAP (glial fibrillary acidic protein) — class III intermediate filament; upregulated in reactive gliosis |
| Additional markers | Vimentin, nestin (immature/reactive); S100β (cytoplasmic Ca²⁺ sensor); glutamine synthetase (GS, astrocyte-specific); AQP4 (endfeet; orthogonal arrays) |
| Gap junctions | Cx43 and Cx30 link astrocytes into a functional syncytium for K⁺ redistribution and metabolite sharing |
| Perivascular endfeet | Envelop >99% of cerebral capillary surface; AQP4 (OAPs) and Kir4.1 enriched; signal endothelium to maintain BBB tight junctions |
| Protoplasmic (grey matter) | Highly ramified, bushy; thin perisynaptic astrocytic processes (PAPs, ~0.1–0.5 µm) penetrate deep into neuropil; ~140,000 synapses/cell |
| Fibrous (white matter) | Longer, less branched processes; lower GFAP density per volume; wrap nodes of Ranvier |
| Bergmann glia (cerebellum) | Radial processes guide Purkinje cell dendritic arborisation; GLAST-rich; essential for cerebellar circuit formation |
| Müller glia (retina) | Radial glia spanning all retinal layers; analogous astrocytic support functions in the eye |
Function — Key Pathways
1. Astrocyte-Neuron Lactate Shuttle (ANLS). Astrocytes are the primary CNS glycogen reservoir (~100 µmol/g wet brain). During neural activity:
This shuttle provides neurons oxidative fuel without competing for glucose. Glycogen mobilisation sustains lactate output during intense firing or hypoglycaemia.
2. Glutamate-Glutamine Cycle. Astrocytes express GLT-1 (EAAT2) and GLAST (EAAT1) — responsible for >90% of synaptic glutamate clearance. Cleared glutamate is amidated by glutamine synthetase (GS, astrocyte-specific): Glutamate + NH₃ → Glutamine (GS). Glutamine is released and taken up by neurons, which regenerate glutamate (PAG) or GABA (GAD) from it. GABA is recycled via GAT-3 on astrocyte membranes.
3. K⁺ Spatial Buffering. Action potentials release K⁺ into extracellular space. Astrocytic Kir4.1 channels absorb this K⁺ and redistribute it through the gap-junction syncytium to regions of lower K⁺ concentration, preventing accumulation above the seizure threshold (~12 mM vs. resting ~3 mM).
4. Tripartite Synapse and Gliotransmission. Astrocytes detect synaptic activity via mGluR2/3/5 and P2Y receptors → intracellular Ca²⁺ elevation → release of gliotransmitters:
| Gliotransmitter | Receptor(s) | Effect |
|---|---|---|
| D-serine | NMDA NR2B co-agonist site | Enables LTP induction (NMDA co-activation) |
| ATP → Adenosine | A1 (inhibitory) / A2A (facilitatory) | Synaptic depression or facilitation depending on context |
| Glutamate | mGluRs, NMDA | Slow inward currents; synchronise neuronal networks |
| GABA | GABA-A | Tonic inhibition in cerebellum and hippocampus |
5. Neurovascular Coupling. Astrocyte Ca²⁺ waves propagate to perivascular endfeet → arachidonic acid (AA) metabolised to PGE₂ (vasodilatory, EP receptors on smooth muscle), EETs (vasodilatory, K⁺ channels), or 20-HETE (vasoconstrictive under high activity). This provides the cellular basis for functional hyperaemia — the fMRI BOLD signal.
6. BBB Maintenance and Synaptogenesis. Astrocyte endfeet upregulate endothelial tight junctions (claudin-5, occludin, ZO-1) via angiopoietin-1/Tie2 and TGF-β signaling. AQP4 prevents oedema. Astrocytes also secrete synaptogenic factors: thrombospondins 1/2 (via α2δ-1 receptor → silent synapse induction), glypicans 4/6 (→ AMPA receptor clustering), hevin (NrCAM organiser).
Lifecycle — Development and Reactive Gliosis
Development. Astrocytes are born late in neurogenesis via a gliogenic switch driven by Notch/RBPJ, JAK/STAT3 (CNTF, LIF → pSTAT3), and BMP2/4/SMAD signaling. Radial glial cells (neural stem cells) asymmetrically divide to produce astrocyte daughters that progressively mature, retract radial processes, and elaborate territorial processes in the postnatal period.
Reactive Astrogliosis. Brain injury (TBI, stroke, MS, SCI, ALS, neurodegeneration) triggers a graded response:
Mild/Moderate Gliosis (isomorphic)
⇧GFAP, ⇧vimentin, process hypertrophy; domain organisation preserved; neuroprotective: trophic factor secretion (GDNF, BDNF), antioxidant (Nrf2), BBB repair. NF-κB pathway drives cytokine-mediated activation.
Severe Gliosis → Glial Scar (anisomorphic)
Proliferation, migration, loss of domain organisation → CSPG-rich scar (brevican, neurocan, versican, aggrecan). Limits lesion spread but inhibits axon regeneration. STAT3 drives scar formation; CSPG digestion by chABC promotes regeneration in animal models.
Pathology
Neuromyelitis Optica (NMO / NMOSD)
Anti-AQP4 IgG (NMO-IgG) targets perivascular astrocyte endfeet → complement-mediated astrocyte destruction → inflammatory demyelinating lesions in optic nerve and spinal cord. Severe, relapsing attacks; distinct from MS. Treated with rituximab, eculizumab, inebilizumab.
Glioblastoma (GBM)
Grade IV astrocytic tumour; IDH-wildtype; EGFR amplification, PTEN deletion, TERT promoter mutation. Diffusely infiltrating. Median survival ~15 months despite surgery + radiotherapy + temozolomide. ~3/100,000/year; most lethal primary brain tumour.
Alexander Disease
Gain-of-function GFAP mutations → Rosenthal fibres (GFAP aggregates in astrocytes). Megalencephalic leukoencephalopathy; infantile/juvenile/adult forms; seizures, ataxia, spasticity. Rare but archetypal primary astrocytopathy.
Hepatic Encephalopathy
Hyperammonaemia → Alzheimer type II astrocyte transformation; glutamine accumulation → osmotic astrocyte swelling (AQP4 upregulation); impaired K⁺ buffering (Kir4.1 downregulation) → neurological impairment. Reverses with ammonia reduction.
Epilepsy
Loss of Kir4.1 or GLT-1/GLAST function → impaired K⁺ and glutamate buffering → elevated extracellular [K⁺] and [Glu] → neuronal hyperexcitability → seizures. Reactive gliosis from seizures further impairs buffering in a vicious cycle.
Astrogliosis in Neurodegeneration (AD, ALS, PD)
In all major neurodegenerative diseases, reactive astrocytes adopt A1 (neurotoxic, NF-κB-driven, complement secreting) or A2 (neuroprotective, STAT3-driven) phenotypes. A1 astrocytes lose glutamate uptake, K⁺ buffering, and synaptogenic function — amplifying neuronal damage.
Cross-Atlas Connections
References
- Alberts B, Johnson A, Lewis J, et al. Molecular Biology of the Cell. 7th ed. W.W. Norton; 2022. NCBI Bookshelf
- Hall JE, Hall ME. Guyton and Hall Textbook of Medical Physiology. 14th ed. Elsevier; 2021. Elsevier
- Pellerin L, Magistretti PJ. Glutamate uptake into astrocytes stimulates aerobic glycolysis: a mechanism coupling neuronal activity to glucose utilization. Proc Natl Acad Sci USA. 1994;91(22):10625–10629. doi:10.1073/pnas.91.22.10625
- Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119(1):7–35. doi:10.1007/s00401-009-0619-8 · PubMed 20012068